• 1
    Yerby MS. Problems and management of the pregnant woman with epilepsy. Epilepsia 1987;20(suppl 3):S2936.
  • 2
    Yerby MS, Friel PN, McCormick K, et al. Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding. Epilepsy Res 1990;5:2238.
  • 3
    Tomson T, Lindbom U, Ekqvist B, Sundqvist A. Epilepsy and pregnancy: a prospective study of seizure control in ralation to free and total plasma concentrations of carbamazepine and phenytoin. Epilepsia 1994;35:12230.
  • 4
    Tomson T, Lindbom U, Ekqvist B, Sundqvist A. Disposition of carbamazepine and phenytoin in pregnancy. Epilepsia 1994;35:1315.
  • 5
    Eldridge RR, Tennis P. Monitoring birth outcomes in the lamotrigine pregnancy registry [Abstract]. Epilepsia 1995;36(suppl 4):90.
  • 6
    Forsblad E, Eriksson A-S, Beck O. Liquid chromatographic determination of plasma lamotrigine in pediatric samples. J Pharmaceutical and Biomedical Analysis 1996;14:7558.
  • 7
    Parsons DN, Dickins M, Morley TJ. Lamotrigine, absorption, distribution, and excretion. In: LevyRH, MattsonRH, MeldrumBS, eds. Antiepileptic drugs, 4th ed. New York : Raven Press, 1995: 87781.
  • 8
    Rambeck B, Wolf P. Lamotrigine clinical pharmacokinetics. Clin Pharmacokinet 1993;25:43343.
  • 9
    Besunder JB, Reed MD, Blumer JL. Principles of drug disposition in the neonate. a critical evaluation of the pharmacokinetic/pharmacokinetic interface (part I). Clin Pharmacokinet 1988;14: 189216.
  • 10
    Kilpatrick ES, Forrest G, Brodie MJ. Concentration-effect and concentration-toxicity relations with lamotrigine. Epilepsia 1996;37:5348.
  • 11
    Rambeck B, Kurlemann G, Stodieck SRG, May TW, Jurgens U. Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child. Eur J Clin Pharmacol 1997;51:4814.